Recordati Industria Chimica e Farmaceutica S.p.A. (0KBS.IL)
| Previous close | 51.38 |
| Open | 51.60 |
| Bid | 51.80 x 0 |
| Ask | 54.00 x 0 |
| Day's range | 51.45 - 52.90 |
| 52-week range | 40.02 - 53.40 |
| Volume | |
| Avg. volume | 14,477 |
| Market cap | 10.992B |
| Beta (5Y monthly) | 0.33 |
| PE ratio (TTM) | 28.44 |
| EPS (TTM) | 1.86 |
| Earnings date | N/A |
| Forward dividend & yield | 1.20 (2.71%) |
| Ex-dividend date | 22 May 2023 |
| 1y target est | N/A |
- Reuters
UPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reports
CVC Capital Partners is exploring options for its controlling stake in Italian pharmaceutical group Recordati SpA, Bloomberg News reported on Tuesday, citing people familiar with the matter. CVC and Recordati did not immediately respond to a Reuters request for comments. A CVC-led consortium of investment funds had agreed to buy 51.8% of Recordati in a deal worth about 3 billion euros in 2018.
BloombergCVC Explores Options for €11 Billion Drugmaker Recordati
(Bloomberg) -- CVC Capital Partners is exploring options for its controlling stake in Italian drugmaker Recordati SpA, according to people familiar with the matter.Most Read from BloombergRay Dalio’s Famous Trade Is Sputtering, Investors BailingTesla Stock in ‘No Man’s Land’ After 43% Rout Ahead of EarningsBillionaire Pinaults Fight to Pull Gucci Off the Discount Rack‘Mag Seven’ Jump Minutes Away From Tesla’s Results: Markets WrapTaylor Swift Is Proof That How We Critique Music Is BrokenThe buyo
